āMailmanā gene-editing tool carries molecule to exact āzip codeā
HQ Team May 24, 2025: Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
HQ Team May 24, 2025: Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases.
HQ Team May 8, 2025: In a surprising and concerning trend, new research from theĀ National Institutes of Health (NIH)Ā reveals thatĀ 14 types of cancerĀ are.
HQ Team April 15, 2025: Pfizer Inc. stopped its trial of danuglipron for treating chronic weight management after an asymptomatic patient developed a.
HQ Team April 10, 2025: Ā Sonia Vallabh, a graduate of Harvard Law School and her husband Ā Eric Minikel, who holds a planning degree.
HQ Team February 20, 2025 ā Researchers from Osaka University have identified a protein, AP2A1, that could hold the key to reversing.
Georgia Tech researchers have developed a prototype 3D-printed, bioresorbable heart valve that promotes tissue regeneration, potentially eliminating the need for repeated surgeries for.
Novartis AG, one of the worldās top 10 pharmaceutical companies in terms of revenue, will acquire US-based Anthos Therapeutics Inc. for $3.1 billion.
Billionaire Gautam Adaniās family plans to invest 60 billion rupees ($686.18 million) to set up two health campuses in the Indian cities of.
Scientists have created an atlas of individual cells within the human brain region of the hypothalamus and identified new genes linked to obesity.
AstraZenecaās drug for treating limited-stage small cell lung cancer got a recommendation for approval from an EU regulator panel, according to the British-Swedish.